EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

XTB Stock Falls 8% as Investors Fear KNF Will Deepen Its CFD Review

Posted: 27th May 2026

XTB shares fell more than 8% today (Wednesday) to close below 100 zlotys, the Warsaw-listed broker's sharpest single-session decline in months and a striking reversal of the rally that carried the stock to a record 114 zlotys in April.

Trading volume ran more than 50% above the three-month daily average, signaling institutional positioning rather than retail noise.

A Sell-Off Without an Obvious Catalyst

XTB did not publish an ESPI disclosure on Wednesday. Poland's Financial Supervision Authority did not announce a new investigation, sanction, or rule. No analyst note circulated that would account for an 8% repricing of one of the Warsaw exchange's best-performing stocks of 2026.

Polish financial press has connected the slide to renewed unease about the KNF's ongoing review of how Contracts for Difference are sold to retail clients. That review, and the regulator's thinking around it, has been public knowledge for weeks.

“Many investors appear to have been spooked by media reports - which, in my view, were somewhat overinterpreted - suggesting that the KNF intends to take a tougher stance on CFDs,” Arkadiusz Jóżwiak, the Editor-in-Chief at Comparic.pl, commented for FinanceMagnates.com “The old market adage is to buy the rumor. This time, however, we witnessed investors selling it.”

As FinanceMagnates.com reported earlier this month, KNF vice-chairman Dariusz Adamski said the "capital market cannot function like gambling" and confirmed the regulator was widening its CFD review.

What is unclear is why the same regulatory thesis the market discounted two weeks ago would today drive XTB shares more than 8% lower on outsized volume.

A Different Reaction From Six Weeks Ago

The contrast with April makes the move more conspicuous. On April 13, KNF imposed a 20 million zloty ($5.5 million) fine on XTB over MiFID II breaches in client onboarding between 2022 and 2023. The stock rose the following day and kept climbing, hitting an all-time high of around 114 zlotys just over a week later. A confirmed financial penalty did not dent the rally.

Six weeks later, with no new fine, no new XTB filing, and no fresh regulator action, the same stock has given back roughly 11% of its value from the April peak in a single day.

Broader Regulatory Pressure on CFDs Is Building Across Europe

The Polish regulator is not acting in isolation. The European Securities and Markets Authority has spent more than two years tightening supervisory expectations around retail leveraged products, and earlier this year acknowledged that MiFID II rules had become too complex for many ordinary investors, while continuing to scrutinize CFD providers' marketing and product design.

In February, ESMA also confirmed that perpetual futures meeting the CFD definition fall under the same retail restrictions as traditional CFDs, closing a workaround several crypto-linked brokers had been testing.

Spain's CNMV imposed sweeping curbs on CFD advertising in 2023, and Cyprus's CySEC has tightened oversight of retail-facing client acquisition for the same products.

Within that landscape, KNF has emerged as one of the more active CFD supervisors in the EU. Its widened review puts the Polish market on a similar trajectory to the gradual tightening seen in France, Spain, and the Netherlands over the past several years.

CFDs Still Power a Business That Sells Stocks and ETFs

The reason regulatory chatter, even without a fresh development, can move XTB shares this much is the broker's revenue mix. Although XTB markets equities, exchange-traded funds, and investor education to Polish retail clients alongside its CFD offering, leveraged contracts remain by far the largest profit driver.

Arnaout has acknowledged this directly, telling Polish media that "around 95%, or maybe even more, of revenue is generated from CFD instruments." He has framed diversification, including spot crypto and options, as a multi-year project rather than a near-term offset.

That dependence is why strong fundamentals failed to cushion Wednesday's reaction. XTB's first-quarter 2026 results showed net profit of 535 million zlotys, up 176% year over year, on operating income of 1.09 billion zlotys and 370,000 new clients added in a single quarter.

Noble Securities analysts have flagged a full-year 2026 net profit run-rate of around 1 billion zlotys, contingent on the broker maintaining current monetization rates. None of that protected the share price on Wednesday.

What Investors Will Watch Next

Without an official trigger to anchor the move, the next reference points are external. KNF has not yet published concrete proposals on new leverage caps, marketing restrictions, or suitability-test changes, nor a timeline for public consultation.

Whether any future measures will apply only to Poland or extend to XTB's FCA-regulated and CySEC-regulated units is also unclear. Sell-side analysts covering the broker may issue revision notes in the coming days as they recalibrate regulatory risk into existing models targeting a billion-zloty annual profit.

For now the stock trades roughly 22% above its 52-week low of 61.86 zlotys but about 11% below the April record, leaving room for further repricing if the regulatory outlook hardens or if whatever drove Wednesday's volume returns.

This article was written by Damian Chmiel at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross